RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Golan, Talia, Khvalevsky, Elina Zorde, Hubert, Ayala, Gabai, Rachel Malka, Hen, Naama, Segal, Amiel, Domb, Abraham, Harari, Gil +10 more·2015·Oncotarget
DOI 10.18632/oncotarget.4183

Cited by (336)

Items 101–200 of 336

  1. Next-generation therapies for pancreatic cancer
    Conor W. Buckley, Eileen Mary O'Reilly · 2024 · Expert Review of Gastroenterology & Hepatology
  2. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas
    Neetha Parameswaran, Courtney A. Bartel, Wilnelly M. Hernandez-Sanchez, Kristy L. S. Miskimen, Jacob M. Smigiel, Ahmad Mohammad Khalil, Mark W. Jackson · 2019 · Scientific Reports
  3. Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib
    Cong He, Doulathunnisa Jaffar Ali, Huantian Xu, Subhashree Kumaravel, Ke Si, Yumin Li, Bo Sun, Junqing Ma, Zhongdang Xiao · 2020 · Experimental Cell Research
  4. RNA Therapeutics: How Far Have We Gone?
    Maria Francisca Coutinho, Liliana Matos, Juliana Inês Santos, Sandra Alves · 2019 · Advances in experimental medicine and biology
  5. Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment
    Keiko Yamakawa, Yuko Nakano‐Narusawa, Nozomi Hashimoto, Masanao Yokohira, Yoko Matsuda · 2019 · International Journal of Molecular Sciences
  6. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
    Daniela Loessner, Peter Goettig, Sarah Preis, Johanna Felber, Holger Bronger, Judith Ann Clements, Julia Dorn, Viktor Magdolen · 2018 · Expert Opinion on Therapeutic Targets
  7. Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes
    Marie Rouanet, Marine Lebrin, Fabian Gross, Barbara Bournet, Pierre Cordelier, Louis Buscail · 2017 · International Journal of Molecular Sciences
  8. Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
    Damiano Bartolucci, Andrea Pession, Patrizia Hrelia, Roberto Tonelli · 2022 · Pharmaceutics
  9. Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases
    Harshini Kurakula, Swetha Vaishnavi, Mohammed Yaseen Sharif, Satheesh Ellipilli · 2023 · ACS Omega
  10. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
    Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, Veera Venkata Satyanarayana Reddy Karri, Jerry Nesamony, Chelliah Selvam, Mahendran Bhaskaran · 2024 · Cancer Letters
  11. Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review
    Ritu Singh, Johanna Goldberg, Anna M. Varghese, Kenneth H. Yu, Wungki Park, Eileen Mary O'Reilly · 2019 · Cancer Treatment Reviews
  12. Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine
    Bingyu Li, Qiong Zhang, Claire N. Castaneda, Shelly M. Cook · 2024 · Biomedicines
  13. The Talented LncRNAs: Meshing into Transcriptional Regulatory Networks in Cancer
    Dana Segal, Josée Dostie · 2023 · Cancers
  14. Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer
    Ida Franiak Pietryga, Barbara Ziemba, Bradley T. Messmer, Dorota Skowronska‐Krawczyk · 2018 · InTech eBooks
  15. Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
    Giulia Brachi, Federico Bussolino, Gianluca Ciardelli, Clara Mattu · 2019 · Frontiers in Bioengineering and Biotechnology
  16. Targeting angiotensinogen with RNA-based therapeutics
    Liwei Ren, Katrina M. Mirabito Colafella, Dominique M. Bovée, Estrellita Uijl, A.H. Jan Danser · 2019 · Current Opinion in Nephrology & Hypertension
  17. Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
    Dima Hattab, Athirah Bakhtiar · 2020 · Pharmaceutics
  18. Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
    Hang Sheng Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao · 2022 · 癌症：英文版
  19. Moving beyond nanotechnology to uncover a glimmer of hope in diabetes medicine: Effective nanoparticle‐based therapeutic strategies for the management and treatment of diabetic foot ulcers
    Ahmad Hosseinzadeh, Ali Zamani, Hamed Ghoddusi Johari, Ahmad Vaez, Ali Golchin, Lobat Tayebi, Ehsan Vafa, Milad Abbasi, Ali Mohammad Amani, Shreeshivadasan Chelliapan et al. · 2023 · Cell Biochemistry and Function
  20. Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
    Friederike Inga Nollmann, Dietrich Alexander Ruess · 2020 · Biomedicines
  21. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer
    Ri Huang, Hong Du, Liang Cheng, Peizhuo Zhang, Fenghua Meng, Zhiyuan Zhong · 2023 · Acta Biomaterialia
  22. Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
    Jenny G. Parvani, Mark W. Jackson · 2017 · Endocrine Related Cancer
  23. Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs
    Rebecca A. Jackson, Ee Sin Chen · 2016 · Pharmacology & Therapeutics
  24. Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues
    Tamara G. Dacoba, Shubaash Anthiya, Germán Berrecoso, Iago Fernández‐Mariño, Carmen Fernández‐Varela, José Crecente‐Campo, Desirée Teijeiro‐Osorio, Fernando Torres, Marı́a José Alonso · 2021 · Advanced Functional Materials
  25. Recent development of gene therapy for pancreatic cancer using non-viral nanovectors
    Yu Liu, Wei Wu, Yiyao Wang, Shisong Han, Yuanyuan Yuan, Jinsheng Huang, Xintao Shuai, Zhao Meng Peng · 2021 · Biomaterials Science
  26. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities
    Wilson Huang, Doru Paul, George A. Călin, Recep Bayraktar · 2023 · Cells
  27. Receptor-mediated delivery of therapeutic RNA by peptide functionalized curdlan nanoparticles
    Tsogzolmaa Ganbold, Shuqin Han, Agula Hasi, Huricha Baigude · 2018 · International Journal of Biological Macromolecules
  28. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis
    Amal T. Qattan, Taher Al‐Tweigeri, Wafa Alkhayal, Kausar Suleman, Asma M. Tulbah, Suad M. Bin Amer · 2021 · Genes
  29. Critical role of KRAS mutation in pancreatic ductal adenocarcinoma
    Zhiyao Fan, Kun Fan, Chao Yan, Qiuyi Huang, Yitao Gong, He Cheng, Kaizhou Jin, Chen Liu, Quanxing Ni, Xianjun Yu et al. · 2018 · Translational Cancer Research
  30. Multistep, effective drug distribution within solid tumors
    Amotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai, Abraham Jacob Domb, Yechezkel Barenholz · 2015 · Oncotarget
  31. Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage
    Fan Guo, Yan Li, Wenjun Yu, Yuanlei Fu, Jing Zhang, Haiqiang Cao · 2024 · Molecular Pharmaceutics
  32. Tumour-bound RNA-laden exosomes
    Sander A. A. Kooijmans, Pieter Vader, Raymond Michel Schiffelers · 2017 · Nature Biomedical Engineering
  33. Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies
    Enni-Kaisa Mustonen, Tiina Palomäki, Markku Pasanen · 2017 · Regulatory Toxicology and Pharmacology
  34. A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
    Samaresh Sau, Katyayani Tatiparti, Hashem O. Alsaab, Sushil K. Kashaw, Arun K. Iyer · 2018 · Drug Discovery Today
  35. Role of Gene Therapy in Pancreatic Cancer—A Review
    Mizuho Sato‐Dahlman, Keith M. Wirth, Masato Yamamoto · 2018 · Cancers
  36. Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations
    Rui Liu, Xiaman Wang, Ying Shen, Aili He · 2021 · Molecular Biology Reports
  37. Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities
    Michael S. Lee, Shubham Pant · 2021 · American Society of Clinical Oncology Educational Book
  38. TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy
    Shuwen Cao, Chunhao Lin, Xiuling Li, Yixia Liang, Phei Er Saw · 2021 · International Journal of Nanomedicine
  39. Targeting KRAS in Pancreatic Cancer
    Darren Cowzer, Mohammed Zameer, Michael R. Conroy, Walter Kölch, Austin G. Duffy · 2022 · Journal of Personalized Medicine
  40. Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy
    Xiao Liang, Li Liu, Yu-Quan Wei, Guangping Gao, Xiawei Wei · 2018 · Human Gene Therapy
  41. The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways
    Rodrigo E. Cáceres-Gutiérrez, Yair Alfaro‐Mora, Marco A. Andonegui, José Díaz‐Chávez, Luis A. Herrera · 2022 · Frontiers in Cell and Developmental Biology
  42. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
    Maxime Rémond, Anna Pellat, Catherine Brézault, Marion Dhooge, Romain Coriat · 2022 · ESMO Open
  43. Developments in Mirna Gene Signaling Pathways in Pancreatic Cancer
    Christina Vorvis, Μαρίνα Κουτσιούμπα, Dimitrios Iliopoulos · 2016 · Future Oncology
  44. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress
    Bogdan Razvan Dume, Emilia Licărete, Manuela Banciu · 2024 · Molecular Therapy — Nucleic Acids
  45. RNAi-Based Approaches for Pancreatic Cancer Therapy
    Min Ju Kim, Hyeyoun Chang, Gi‐Hoon Nam, Youngji Ko, Sun Hwa Kim, Thomas M. Roberts, Ju Hee Ryu · 2021 · Pharmaceutics
  46. RAS‐targeted cancer therapy: Advances in drugging specific mutations
    Cen Liu, Danyang Ye, Hongliu Yang, Xu Chen, Zhijun Su, Xia Li, Mei Ding, Yonggang Liu · 2023 · MedComm
  47. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
    Tang, Yaqin, Liu, Xingyou, Sun, Meng, Xiong, Su, Xiao, Nianting, Li, Jianchao, He, Xiao, Xie, Jing · 2023 · Pharmaceutics
  48. Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application
    Éva Márton, Alexandra Ildikó Varga, Dóra Domoszlai, Gergely Buglyó, Anita Balázs, András Penyige, István Balogh, Bálint Nagy, Melinda Szilágyi · 2025 · Cancers
  49. Changing the course of pancreatic cancer – Focus on recent translational advances
    Milind M. Javle, Talia Golan, Anirban Maitra · 2016 · Cancer Treatment Reviews
  50. Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
    A. V. Kuznetsova, О. П. Попова, Dmitry Nikolayevich Panchenkov, Т. G. Dyuzheva, Ivanov Aa · 2022 · Clinical and Experimental Medicine
  51. Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking
    Marta Portela, Berta Segura‐Collar, Irene Argudo García, Almudena Sáiz, Ricardo Gargini, Pilar Sánchez‐Gómez, Sergio Casas‐Tintó · 2018 · Glia
  52. Current Approaches to Epigenetic Therapy
    Ekaterina D. Griazeva, Daria M. Fedoseeva, Elizaveta I. Radion, Pavel V. Ershov, Ivan Olegovich Meshkov, Alexandra V. Semyanihina, Anna S. Makarova, Valentin Vladimirovich Makarov, Vladimir Sergeevich Yudin, Anton Arturovich Keskinov et al. · 2023 · Epigenomes
  53. Targeting RAS in neuroblastoma: Is it possible?
    Lei Lin, Lei Miao, Huiran Lin, Jiwen Cheng, Meng Li, Zhenjian Zhuo, Jing He · 2021 · Pharmacology & Therapeutics
  54. Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment
    Lingxi Jiang, Qi Yao, Lei Yang, Yang‐Bao Miao, Weiming Ren, Hongmei Liu, Yi Huang, SHAN HU HUANG, Shiyin Chen, Yi Shi et al. · 2023 · Asian Journal of Pharmaceutical Sciences
  55. Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment
    Shenda Gu, Worapol Ngamcherdtrakul, Moataz M. Reda, Zhi Hu, Joe W. Gray, Wassana Yantasee · 2018 · PLoS ONE
  56. Research progress on non-protein-targeted drugs for cancer therapy
    Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Cheong Huang, Ye Yang · 2023 · Journal of Experimental & Clinical Cancer Research
  57. Current Status and Trends in Nucleic Acids for Cancer Therapy: A Focus on Polysaccharide‐Based Nanomedicines
    Chiara Molinar, Maria Tannous, Domitilla Meloni, Roberta Cavalli, Anna Scomparin · 2023 · Macromolecular Bioscience
  58. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA
    Connie Duong, Sakiko Yoshida, Cathy Yi-Hsuan Chen, Gustavo A. Barisone, Elva Dı́az, Yueju Li, Laurel A. Beckett, Jong Hee Chung, Reuben Antony, Jan A. Nolta et al. · 2017 · Pediatric Research
  59. Clinical update on K-Ras targeted therapy in gastrointestinal cancers
    Shubham Pant, Joleen Marie Hubbard, Erika Martinelli, Tanios Bekaii‐Saab · 2018 · Critical Reviews in Oncology/Hematology
  60. Nonviral siRNA delivery systems for pancreatic cancer therapy
    Shahin Aghamiri, Pourya Raee, Sam Talaei, Samira Mohammadi‐Yeganeh, Shiva Bayat, Delsuz Rezaee, Afshin Abdi Ghavidel, Alireza Teymour, Soheil Roshanzamiri, Shohreh Farhadi et al. · 2021 · Biotechnology and Bioengineering
  61. Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients?
    Kamila Krupa, Marta Magdalena Fudalej, Emilia Włoszek, Hanna Miski, Anna Maria Badowska-Kozakiewicz, Dominika Mękal, Michał Piotr Budzik, Aleksandra Izabela Czerw, Andrzej Deptała · 2025 · Cancers
  62. Endoscopic Ultrasound-Guided Treatment of Pancreatic Cancer
    Irina Mihaela Cazacu, Ben S. Singh, Adrian Săftoiu, Manoop S. Bhutani · 2020 · Current Gastroenterology Reports
  63. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers
    Karolina Elżbieta Kaczor‐Urbanowicz, Jordan C. Cheng, Jonathan C. King, Alireza Sedarat, Stephen Jacob Pandol, James J. Farrell, David T. Wong, Yong H. Kim · 2020 · Pancreas
  64. Small interfering RNA: From designing to therapeutic in cancer
    Jyoti Singh, Abdulaziz S. Saeedan, Gaurav Kaithwas, Mohd Nazam Ansari · 2025 · Journal of Genetic Engineering and Biotechnology
  65. MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review
    Roshanak Shams, Hamid Asadzadeh Aghdaei, Ali Behmanesh, Amir Sadeghi, Mohammadreza Zali, Sina Salari, José M Padrón · 2020 · Cancer Management and Research
  66. Cut and Paste for Cancer Treatment: A DNA Nanodevice that Cuts Out an RNA Marker Sequence to Activate a Therapeutic Function
    Tatiana A. Molden, Caitlyn T. Niccum, Dmitry M. Kolpashchikov · 2020 · Angewandte Chemie International Edition
  67. Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
    Shota Oyama, Tsuyoshi Yamamoto, Asako Yamayoshi · 2021 · Cancers
  68. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
    Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia De Castro-Martinez, Adoración Romero-Bazán, Miguel Ángel Álvarez-Mon, Jorge Monserrat et al. · 2022 · Cancers
  69. Molecular Targets for the Diagnosis and Treatment of Pancreatic Cancer
    Robert G. Pergolizzi, Steven T. Brower · 2024 · International Journal of Molecular Sciences
  70. Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
    Eun-Jeong Won, Hyeji Park, Tae‐Jong Yoon, Young‐Seok Cho · 2022 · Pharmaceutics
  71. RNA nanotechnology: A new chapter in targeted therapy
    Tongtong Lv, Yingying Meng, Yifan Liu, Yukun Han, Hongwu Xin, Xiaochun Peng, Jinbai Huang · 2023 · Colloids and Surfaces B Biointerfaces
  72. Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system
    Liangliang Hao, Natalie Boehnke, Susanna K. Elledge, Nour Saida Harzallah, Renee Tan Zhao, Eva Cai, Yuxiong Feng, Sofia Neaher, Heather E. Fleming, Piyush B. Gupta et al. · 2024 · Proceedings of the National Academy of Sciences
  73. The trend toward more target therapy in pancreatic ductal adenocarcinoma
    Chiara Deiana, Margherita Agostini, Giovanni Brandi, Elisa Giovannetti · 2024 · Expert Review of Anticancer Therapy
  74. Current status of nucleic acid therapy and its new progress in cancer treatment
    Wenting Lou, Leqi Zhang, Jianwei Wang · 2024 · International Immunopharmacology
  75. Exosomes for targeting KRAS in the treatment of pancreatic cancer
    Louis Buscail · 2017 · Nature Reviews Gastroenterology & Hepatology
  76. Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells
    Fernando Francisco Borges Resende, Simoneide Souza Titze-de-Almeida, Ricardo Titze‐de‐Almeida · 2018 · Oncology Letters
  77. KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
    Qingda Meng, Davide Valentini, Martin Rao, Markus J. Maeurer · 2018 · Frontiers in Oncology
  78. A Phase II Trial of an Extended-Release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
    Brinda Alagesan, Anna M. Varghese, Celina Ang, Martín Gutiérrez, Moshe Kamar, Maria Passhak, Ravit Geva, Nirit Yarom, Maor Lahav, Rosario Ligresti et al. · 2026 · Clinical Cancer Research
  79. Antitumoral RNA ‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies
    Hiroaki Taniguchi, Yasunori Suzuki, Kohzoh Imai, Yasushi Adachi · 2022 · Cancer Science
  80. Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer
    Majd Agbaria, Doaa Jbara-Agbaria, Etty Grad, Meital Ben-David-Naim, Gil Aizik, Gershon Golomb · 2023 · Journal of Controlled Release
  81. Nano Drug Delivery Systems: A Mini-review
    C. Valli Nachiyar, Swetha Sunkar, S. Karthick Raja Namasivayam, Jayshree Nellore · 2023 · Nanoscience &amp Nanotechnology-Asia
  82. Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
    Raj Kishore, Ajit Magadum · 2024 · Journal of Cardiovascular Development and Disease
  83. Nanotechnology as a Delivery Tool for Precision Cancer Therapies
    Bhawna Sharma, Rachael M. Crist, Pavan P. Adiseshaiah · 2017 · The AAPS Journal
  84. Gene Therapy for Pancreatic Diseases: Current Status
    Kenya Kamimura, Takeshi Yokoo, Shuji Terai · 2018 · International Journal of Molecular Sciences
  85. Polymeric biomaterials for cancer nanotechnology
    Jianjun Cheng, Suzie Hwang Pun · 2015 · Biomaterials Science
  86. Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
    Rushikesh Fopase, Chinmaya Panda, Amarnath Praphakar Rajendran, Hasan Uludağ, Lalit Mohan Pandey · 2023 · Frontiers in Bioengineering and Biotechnology
  87. Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells—Function and Therapeutic Potential
    Amanda Katharina Binder, Franziska Bremm, Jan Dörrie, Niels Schaft · 2024 · International Journal of Molecular Sciences
  88. Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia
    Yu Chen, Zhengfeng Yin, Kenneth D. Westover, Zhiwei Zhou, Liping Shu · 2024 · Molecular Cancer Therapeutics
  89. Advancements in gene therapies targeting mutant KRAS in cancers
    Yuhang Wang, Thuy Anh Bui, Xinpu Yang, György Hutvágner, Wei Deng · 2025 · Cancer and Metastasis Reviews
  90. Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells
    Cong He, Doulathunnisa Jaffar Ali, Yumin Li, Yanliang Zhu, Bo Sun, Zhongdang Xiao · 2020 · PeerJ
  91. Pancreatic ductal adenocarcinoma in the era of precision medicine
    Binbin Zheng-Lin, Eileen Mary O'Reilly · 2021 · Seminars in Oncology
  92. Photochemical Internalization of siRNA for Cancer Therapy
    Lamiaa M. A. Ali, Magali Gary‐Bobo · 2022 · Cancers
  93. KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex
    Donald D. Rao, Xiuquan Luo, Zhaohui Wang, Christopher M. Jay, Francis Charles Brunicardi, William A. Maltese, Luisa Manning, Neil N. Senzer, John J. Nemunaitis · 2018 · PLoS ONE
  94. Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer
    Alejandra Vargas, Priyata Dutta, Eileen S. Carpenter, Jorge D. Machicado · 2024 · Diagnostics
  95. Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer
    Richard McKinnon Walsh, Joseph Ambrose, Jarrid L. Jack, Austin E. Eades, Bailey A. Bye, Mariana T. Ruckert, Fanuel Messaggio, Appolinaire A. Olou, Prabhakar Chalise, Dong Pei et al. · 2025 · Journal for ImmunoTherapy of Cancer
  96. Applying Nanotherapeutics to Improve Chemoradiotherapy Treatment for Cancer
    Joseph Michael Caster, Andrew Zhuang Wang · 2017 · Therapeutic Delivery
  97. MicroRNAs as potential therapeutic targets for pancreatic cancer
    Xiangyu Chu, Dan Wei, Xinxin Liu, Di Long, Xiaodong Tian, Yinmo Yang · 2021 · Chinese Medical Journal
  98. Polymers in the Delivery of siRNA for the Treatment of Virus Infections
    Nicholas P. Reynolds, Megan Dearnley, Tracey M. Hinton · 2017 · Topics in Current Chemistry
  99. Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview
    Alberto Larghi, Mihai Rimbaș, Gianenrico Rizzatti, Carmine Carbone, Antonio Gasbarrini, Guido Costamagna, Sergio Alfieri, Giampaolo Tortora · 2021 · Seminars in Oncology
  100. Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes
    Takehiko Tsumura, Keitaro Doi, Hiroyuki Marusawa · 2022 · Cancers